SOLUBILITY ENHANCEMENT OF POOR WATER SOLUBLE DRUGS BY SOLID DISPERSION: A REVIEW
The solubility behavior of drugs remains one of the most exigent aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Among all the newly discovered chemical entities, about 40-45% drugs fail to reach market due to their poor water solubility. Because of solubility problem, bioavailability of drugs gets affected and hence solubility enhancement becomes necessary. Solid dispersions have attracted considerable interest as an efficient means of improving the dissolution rate and hence the bioavailability of drugs. Therefore, the application of this technique proves to be an important stratagem for pharmaceutical companies. However, the in - depth knowledge of the solid dispersion is desired for the scale up of formulation, from laboratory scale to industrial scale. There are various methods available to improve the solubility of the new drug in which solid dispersion emerged promising. A Solid dispersion generally composed of two components- the drug and the polymer matrix. Hence, this approach is expected to form a basis for the commercialization of many poorly water-soluble and water-insoluble drugs in their solid-dispersion formulations in the near future. This article reviews the various preparation techniques, carriers used, advantages and limitations of solid dispersions and compiles some of the recent advances.
Keywords: Bioavailability, Solid Dispersion, Hydrophilic carriers, Polyethylene glycol.
2. Dalvi P., Gerange A., Ingale P. Solid dispersion: strategy to enhance solubility. Journal of Drug Delivery and Therapeutics, 2015; 5(2):20-28. https://doi.org/10.22270/jddt.v5i2.1060NT
3. Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci 2005;8:18-25.R
4. Bhirud Y., Phalak H. Advances in solid dispersion technology and its applications in the development of solid dosage forms. Journal of Drug Delivery and Therapeutics, 2016; 6(6):40-47. https://doi.org/10.22270/jddt.v6i6.1316
5. Zoghbi A., Wang B. Carvedilol solubility enhancement by inclusion complexation and solid dispersion: review. Journal of Drug Delivery and Therapeutics, 2015; 5(2):1-8. https://doi.org/10.22270/jddt.v5i2.1074
6. Khan AD, Singh L, Various techniques of bioavailability enhancement: a review, Journal of Drug Delivery & Therapeutics. 2016; 6(3):34-41. https://doi.org/10.22270/jddt.v6i3.1228
7. Dhirendra K. Solid dispersions: A review. Pak J Pharm Sci 2009; 22(2):234-246.
8. Doney J, Yang J, Baer H, Draganoiu E. Excipients in polymeric Drug Delivery and formulations. Pharm Tech. 2008:96-98.
9. Kerns EH, Li D. Drug-like properties: Concepts, structure, design and methods from ADME to toxicity optimization. Academic Press. 2008: 461.
10. Kalyanwat R, Patel S. Solid dispersion: A method for enhancing drug dissolution International Journal of Drug Formulation & Research. Nov-Dec. 2010, Vol. 1 (iii):1-14.
11. Chiou WL, Riegelman S. Pharmaceutical application of solid dispersion system. J Pharm Sci 1971; 60:1281-1302.
12. Janssens S, de Armas HN, D’Autry W, Van Schepdael A, Van den Mooter G, Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends, European journal of pharmaceutics and biopharmaceutics, 2008, 69(3), 1114-20.
13. Sareen S, Mathew G, Joseph L, Improvement in solubility of poor water-soluble drugs by solid dispersion, International journal of pharmaceutical investigation, 2012, 2(1), 12.
14. Sethia S, Squillante III E, Solid dispersions: revival with greater possibilities and applications in oral drug delivery, Critical Reviews™ in Therapeutic Drug Carrier Systems, 2003, 20(2&3).
15. Vasconcelos T, Sarmento B, Costa P, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs, Drug discovery today, 2007, 12(23), 1068-75.
16. Babu PS, Chowdary KPR. Enhancement of dissolution rate of celecoxib by solid dispersion in superdisintegrants. Ind Drugs. 2008; 45(7):547-552.
17. Kalyanwat R, Patel S. Solid dispersion: A method for enhancing drug dissolution. Int J Drug Form Res. 2010; 1(3):1-14.
18. Sekiguchi K, Obi N. Studies on the absorption of eutectic mixture. I. A comparison of the behaviour of a eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull 1961;9:866-72.
19. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II-experimental evaluation of a eutectic mixture: urea-acetaminophen system. J PharmaSci 1966;55:482-7.
20. Castellan GW. Physical Chemistry, Addison-Wesley, Menlo Park, CA; 1983. p. 324-36.
21. Swarbrick J. ed 3. Encyclopaedia of pharmaceutical technology; 2006. p. 775-7.
22. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J Pharm Sci 1965;54:1145-8.
23. Hume Rotherly W, Raynor GV. The structure of metals and alloys, Institute of Metals, London; 1954.
24. Argade PS, Magar DD, Saudagar RB. Review article on solid dispersion as solubility enhancement technique for poorly water soluble drugs. J Adv Pharm Edu Res 2013;3:427-39.
25. Verma S., Patel U., Patel R. Formulation and evaluation of ivermectin solid dispersion. Journal of Drug Delivery and Therapeutics, 2017; 7(7):15-17. https://doi.org/10.22270/jddt.v7i7.1572
26. Modi A, Tayade P, Enhancement of dissolution profile by solid dispersion (kneading) technique, AAPS PharmSciTech, 2006, 7(3), E87-E92
27. Patel MM, Patel DM. Fast dissolving valdecoxib tablets containing solid dispersion of valdecoxib. Ind J Pharm Sci. 2006: 222-225.
28. Bakatselou V, Oppenheim RC, Dressman JB. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm Res, 1991; 8:1461-9.
29. Al-Marzouqi AH, Jobe B, Dowaidar A, Maestrelli F, Mura P, Evaluation of supercritical fluid technology as preparative technique of benzocaine–cyclodextrin complexes—Comparison with conventional methods, Journal of pharmaceutical and biomedical analysis, 2007; 43(2):566-74.
30. Nokhodchi A, Talari R, Valizadeh H, Jalali MB. An Investigation on the Solid Dispersions of Chlordiazepoxide. International Journal of Biomedical Science 2007; 3(3):210-16.
31. Bhise SB, Rajkumar M. Effect of HPMC on Solubility and Dissolution of Carbamazepine Form III in Simulated Gastrointestinal Fluids. Asian Journal of Pharmaceutics 2008; 2(1):38-42.
32. Goldberg A, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures III - experimental evaluation of griseofulvin- succinic acid solid solution. J Pharm Sci. 1966; 55:487-492.
33. Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R. Studies on mechanism of enhanced dissolution of albendazole solid dispersions with crystalline carriers. Ind J Pharm Sci. 2006; 68:599-607.
34. Serajuddin A., Solid dispersion technique. J. Pharmaceut. Sci., 1999; 88(10):891-900.
35. Kaushal A.M, Guptam P., Bansal AK., Amorphous drug delivery systems: molecular aspects, design, and performance. Crit. Rev. There. Drug Carrier Syst., 2004; 21(3):133-193.
36. Taylor L.S., Zografi G., Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharmaceut. Res., 1997; 14:1691-1698.
37. Cilurzo F., Minghetti P., Casiraghi A., Montanari L., Characterization of nifedipine solid dispersions. Int. J. Pharmaceut., 2002; 242(1-2):313-317.
38. Pikal M.J., Lukes A.L., Lang J.E., Gaines K. Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. J. Pharmaceut. Sci., 1978; 67(6):767-73.
39. Buckton G., Darcy P., The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders. Int. J. Pharmaceut., 1995; 123:265-271.
40. Sebhatu T., Angberg M., Ahlneck C., Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int, J. Pharmaceut., 1995; 104:135-144.
41. Shende M., Fiske P. Fabrication and optimization of novel glipizide sustained release matrices for solubility and dissolution enhancement by solid dispersion through hydrophillic carriers. Journal of Drug Delivery and Therapeutics, 2017; 7(6):38-48. https://doi.org/10.22270/jddt.v7i6.1538
42. Nagasamy V.D.RA., Saraswathi S., Padma Priya M., Khan N. I., Kathirulla N., Sruthi S. Dissolution enhancement of diacerein using water soluble carrier by solid dispersion technology. Journal of Drug Delivery and Therapeutics, 2017; 7(5):33-41. https://doi.org/10.22270/jddt.v7i5.1503
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).